Effectiveness of extending treatment duration in therapy with pegylated interferon and ribavirin for genotype 2 hepatitis C virus infection.
Authors:
- Fusao IkedaFIFusao Ikeda
- Shin-Ichi FujiokaSFShin-Ichi Fujioka
- Yasuyuki ArakiYAYasuyuki Araki
- Kouichi TakaguchiKTKouichi Takaguchi
- Noriaki HashimotoNHNoriaki Hashimoto
- Hiroyuki SekiHSHiroyuki Seki
- Akinobu TakakiATAkinobu Takaki
- Yoshiaki IwasakiYIYoshiaki Iwasaki
- Kazuhide YamamotoKYKazuhide Yamamoto
- 1 January 2015
- journal article
- Vol. 69 (4) , 237-44